semaglutide hepatic impairment child pugh and Liver Cirrhosis: Safety Guide Incretin-based therapies in MASLD/MASH: from

The REDEFINE 2 Trial: Patients with Type 2 Diabetes Published June 2025, the REDEFINE 2 trial investigated adults with both obesity and type 2 diabetes

Where to inject: The patient leaflet advises keeping a 5 cm distance from your belly button

Hair loss on Zepbound (tirzepatide) Zepbound is the same molecule as Mounjaro, prescribed specifically for weight management

Retatrutide is poised to reshape the future of medical weight loss

Ferroptosis, a new form of cell death, and its relationships with tumourous diseases

Further increases to 3 mg or 4.5 mg weekly are available for patients requiring greater HbA1c reduction, though these higher doses are associated with increased gastrointestinal side effects